Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to Entecavir plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B
NCT01023217Phase 4Completed
- Sponsor
- Asan Medical Center
- Start
- Nov 2009
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Asan Medical Center. Started Nov 2009; status: completed.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01023217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01023217.